West Pharmaceutical Services (WST)
EBITDA Growth
14.47%
TTM · Period ending:
WST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported14.47%period ending
Latest reported14.47%period ending
WST TTM EBITDA YoY % (4.36% → 14.47%)
Year-over-year change
High-resolution chart · PNG
WST ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 14.4661% | |
| 15.4036% | |
| 4.217% | |
| 3.749% | |
| -0.5233% | |
| -10.5154% | |
| -11.7877% | |
| -7.0099% | |
| 2.9079% | |
| 4.6905% | |
| 4.5066% | |
| -7.5546% | |
| -18.4095% | |
| -12.6106% | |
| -8.1742% | |
| 7.3404% | |
| 26.8673% | |
| 47.3189% | |
| 70.8625% | |
| 70.1118% | |
| 62.2061% | |
| 44.2752% | |
| 27.6786% | |
| 20.9747% | |
| 13.7567% | |
| 13.8791% | |
| 14.1563% | |
| 13.5284% | |
| 12.7246% | |
| 14.0693% | |
| 8.3103% | |
| 8.9303% | |
| 14.2763% | |
| 1.1257% | |
| 4.0855% | |
| 3.7656% | |
| 20.3748% | |
| 40.2017% | |
| 42.4091% | |
| 40.2848% | |
| -5.6078% | |
| -19.2566% | |
| -19.9126% | |
| -18.6472% | |
| 1.2962% | |
| 14.0493% | |
| 10.012% | |
| 10.6242% | |
| 16.1133% | |
| 20.4181% | |
| 23.4916% | |
| 23.4184% | |
| 15.9056% | |
| 3.4188% | |
| 8.3021% | |
| 17.6471% | |
| 17.9068% | |
| 34.0296% | |
| 27.3533% | |
| 3.414% | |
| 2.1001% | |
| -16.0158% | |
| -11.952% | |
| -5.9545% | |
| 0.8095% | |
| 1.6686% | |
| -12.8728% | |
| -12.78% | |
| 14.4174% | |
| 38.78% | |
| 60.8518% | |
| 20.46% | |
| 20.0523% | |
| 8.2447% | |
| 8.1376% | |
| 8.3333% | |
| 5.9095% | |
| 8.9855% | |
| 29.0043% | |
| 33.4862% | |
| 22.3729% | |
| 19.9305% | |
| 7.4419% | |
| 7.3892% | |
| 18.9516% | |
| 34.2146% | |
| 33.1269% | |
| 28.0757% | |
| 7.2046% | |
| -6.2682% | |
| -10.153% | |
| -16.2483% | |
| 4.6757% | |
| 20.3509% | |
| 52.9787% | |
| 108.5399% | |
| 84.6797% | |
| 29.2517% | |
| -7.6621% | |
| -39.2977% |